BWAY Key Statistics, Chart & Performance
The current stock price of BWAY is 16.965 USD. In the past month the price increased by 5.97%. In the past year, price increased by 80.1%.
BWAY Latest News, Press Relases and Analysis
BWAY Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.14 | 218.16B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.99 | 192.25B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.38 | 137.24B | ||
| SYK | STRYKER CORP | 26.89 | 135.41B | ||
| BDX | BECTON DICKINSON AND CO | 13.93 | 57.34B | ||
| IDXX | IDEXX LABORATORIES INC | 55.84 | 56.23B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.33 | 48.21B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.29 | 38.25B | ||
| RMD | RESMED INC | 25.48 | 36.82B | ||
| DXCM | DEXCOM INC | 36 | 26.12B | ||
| PODD | INSULET CORP | 64.7 | 20.80B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.32 | 18.15B |
Related stock screener links
About BWAY
Company Profile
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Company Info
BRAINSWAY LTD-ADR
16 Hartum Street Rad Tower, 14Th Floor, Har HaHotzvim
JERUSALEM 9777518 IL
CEO: Christopher R. von Jako
Employees: 120
Phone: 97225813140
BRAINSWAY LTD-ADR / BWAY FAQ
What does BWAY do?
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
What is the current price of BWAY stock?
The current stock price of BWAY is 16.965 USD. The price decreased by -2.61% in the last trading session.
Does BRAINSWAY LTD-ADR pay dividends?
BWAY does not pay a dividend.
How is the ChartMill rating for BRAINSWAY LTD-ADR?
BWAY has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the PE ratio for BWAY stock?
The PE ratio for BRAINSWAY LTD-ADR (BWAY) is 15.86. This is based on the reported non-GAAP earnings per share of 1.07 and the current share price of 16.965 USD.
Can you provide the market cap for BRAINSWAY LTD-ADR?
BRAINSWAY LTD-ADR (BWAY) has a market capitalization of 331.85M USD. This makes BWAY a Small Cap stock.
What is the outstanding short interest for BRAINSWAY LTD-ADR?
The outstanding short interest for BRAINSWAY LTD-ADR (BWAY) is 0.31% of its float.
BWAY Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to BWAY. When comparing the yearly performance of all stocks, BWAY is one of the better performing stocks in the market, outperforming 92.07% of all stocks.
BWAY Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to BWAY. BWAY has an excellent financial health rating, but there are some minor concerns on its profitability.
BWAY Financial Highlights
Over the last trailing twelve months BWAY reported a non-GAAP Earnings per Share(EPS) of 1.07. The EPS increased by 260.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.73% | ||
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| Debt/Equity | 0.08 |
BWAY Forecast & Estimates
7 analysts have analysed BWAY and the average price target is 0.12 USD. This implies a price decrease of -99.29% is expected in the next year compared to the current price of 16.965.
For the next year, analysts expect an EPS growth of 68.53% and a revenue growth 13.72% for BWAY